Dusa/Berlex Levulan Actinic Keratoses Recurrence Phase IV Study Planned
Executive Summary
Dusa has committed to a Phase IV study of the actinic keratoses treatment Levulan Kerastick to assess the long-term recurrence rate of treated lesions over a 12-month follow-up period.